Chimio et immuno; éviter le fiasco, PPP en médecine d'urgence, Geneviève Lacroix, 9 oct 2018
Renverser les Anticoagulants oraux (ACO)
Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis. Chaudhary R, Singh A, Chaudhary R, Bashline M, Houghton DE, Rabinstein A, Adamski J, Arndt R, Ou NN, Rudis MI, Brown CS, Wieruszewski ED, Wanek M, Brinkman NJ, Linderbaum JA, Sorenson MA, Atkinson JL, Thompson KM, Aiyer AN, McBane RD 2nd. JAMA Netw Open. 2022 Nov 1;5(11):e2240145. doi: 10.1001/jamanetworkopen.2022.40145. PMID: 36331504.
Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes. van der Horst SFB, Martens ESL, den Exter PL, Bos MHA, van Mens TE, Huisman MV, Klok FA. Thromb Res. 2023 Aug;228:21-32. doi: 10.1016/j.thromres.2023.05.020. Epub 2023 May 29. PMID: 37267671.
Immunothérapie effets secondaires
Management of Toxicities from Immunotherapy: ESMO Clinical Practice Guidelines, Ann Oncol (2017) 28 (suppl 4): iv119–iv142.
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline, DOI: 10.1200/JCO.2017.77.6385 Journal of Clinical Oncology 36, no. 17 (June 10, 2018) 1714-1768.